Our results showed that high expression of AQP2 mRNA had no effect on the prognosis of all ovarian cancer patients, serous ovarian cancer patients, as well as in endometrioid ovarian cancer patients. This evidence concerns the gene AQP2 and ovarian serous adenocarcinoma.